Antibiotics maker Melinta files for Chapter 11 bankruptcy
06 January 2020
Melinta, which filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware, said lenders would acquire the company by exchanging $140 million of claims under their credit facility for all of the company’s equity.
The company’s shares were down 53% at 70 cents on Friday. They are down 62% for the year through Thursday close.
Further reading: Reuters
Author(s): Reuters
Healthy Patients Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
EADA 2023
Emerging Antimicrobials and Diagnostics in AMR 2023
International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands
16/17 November
